KR100784134B1 - 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 - Google Patents
상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 Download PDFInfo
- Publication number
- KR100784134B1 KR100784134B1 KR1020060097734A KR20060097734A KR100784134B1 KR 100784134 B1 KR100784134 B1 KR 100784134B1 KR 1020060097734 A KR1020060097734 A KR 1020060097734A KR 20060097734 A KR20060097734 A KR 20060097734A KR 100784134 B1 KR100784134 B1 KR 100784134B1
- Authority
- KR
- South Korea
- Prior art keywords
- growth factor
- liquid composition
- stabilizer
- epidermal growth
- salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1808—Epidermal growth factor [EGF] urogastrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF] (urogastrone)
Abstract
Description
실시예 1 | 실시예 2 | 실시예 3 | 실시예 4 | 실시예 5 | 비교예 1 | ||
활성성분 | 상피세포성장인자 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
완충제 | 인산일수소나트륨 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
등장화제 | 염화나트륨 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
보존제 | 메틸파라벤 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
점착성 고분자 (점증제) | 폴록사머407 | 6 | 6 | 6 | 6 | 6 | 6 |
안정화제 | EDTA 디소듐염 | 0.5 | |||||
L-히스티딘 | 1 | ||||||
염산 L-아르기닌 | 1 | ||||||
염산 L-라이신 | 1 | ||||||
덱스트란70 | 0.1 | ||||||
수성매질 | 정제수 | 적량 | 적량 | 적량 | 적량 | 적량 | 적량 |
점도(cps) | 500∼700 |
실시예 1 | 실시예 2 | 실시예 3 | 실시예 4 | 실시예 5 | 비교예 1 | |
함량% | 89 | 90 | 85 | 86 | 81 | 52 |
활성% | 90 | 92 | 87 | 85 | 84 | 60 |
실시예 1 | 실시예 2 | 실시예 3 | 실시예 4 | 실시예 5 | 비교예 1 | |
성상 | 맑고 투명함 | 맑고 투명함 | 미량의 응집물 발생(3~4개) | 미량의 응집물 발생(1~3개) | 맑고 투명함 | 뿌옇게 흐려짐 |
여과 후 함량% | 100.0 | 100.0 | 97.2 | 98.1 | 99.9 | 35.9 |
실시예 6 | 실시예 7 | 실시예 8 | 실시예 9 | 실시예 10 | 실시예 11 | ||
활성성분 | 상피세포성장인자 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
완충제 | 인산일수소나트륨 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
등장화제 | 염화나트륨 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
보존제 | 메틸파라벤 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
안정화제 | EDTA 디소듐염 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 |
점착성 고분자 | 폴록사머407 | 10 | |||||
히드록시프로필 메틸 셀룰로오즈 50 cps | 1 | ||||||
히아루론산 나트륨 | 0.1 | ||||||
잔탄검 | 0.2 | ||||||
카보머940 | 0.5 | ||||||
카르복시메틸 셀룰로오즈 나트륨 | 1.5 | ||||||
수성매질 | 정제수 | 적량 | 적량 | 적량 | 적량 | 적량 | 적량 |
점도 (cps) | 1500∼2000 |
실시예 6 | 실시예 7 | 실시예 8 | 실시예 9 | 실시예 10 | 실시예 11 | 비교예 1 | |
사용감 | 7.5 | 10.0 | 9.5 | 9.5 | 9.0 | 10.0 | 7.0 |
착용감 | 7.0 | 9.0 | 9.5 | 8.0 | 9.0 | 8.5 | 2.0 |
비고 | 쓴맛, 아린맛 | 특이사항 없음 | 특이사항 없음 | 특이사항 없음 | 약간 쓴맛 | 특이사항 없음 | 쓴맛, 아린맛 |
실시예 12 | 실시예 13 | 실시예 14 | 실시예 15 | 실시예 16 | ||
활성성분 | 상피세포성장인자 | 0.005 | 0.005 | 0.005 | 0.005 | 0.005 |
완충제 | 인산일수소나트륨 | 0.36 | 0.36 | 0.36 | 0.36 | 0.36 |
등장화제 | 염화나트륨 | 0.87 | 0.87 | 0.87 | 0.87 | 0.87 |
보존제 | 메틸파라벤 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
안정화제 | EDTA 디소듐염 | 0.5 | ||||
L-히스티딘 | 1.0 | 1.0 | 1.0 | |||
점착성 고분자 (점증제) | 폴록사머 407 | 6 | 9 | 9 | ||
히드록시프로필 메틸셀룰로오즈50cps | 1 | |||||
카르복실메틸셀룰로오즈 나트륨 | 1.5 | |||||
수성매질 | 정제수 | 적량 | 적량 | 적량 | 적량 | 적량 |
점도(cps) | 500∼700 | 1200∼1500 |
실시예 12 | 실시예 13 | 실시예 14 | 실시예 15 | 실시예 16 | |
함량% | 90.2 | 100.0 | 99.2 | 99.4 | 98.4 |
활성% | 89.3 | 99.1 | 98.3 | 100.5 | 99.1 |
Claims (10)
- 상피세포성장인자; 점착성 고분자; 및 에틸렌디아민테트라아세트산(ethylenediaminetetraacetic acid, EDTA) 또는 그의 염, 히스티딘, 라이신 또는 그의 무기산염, 아르기닌 또는 그의 무기산염, 및 덱스트란으로 이루어진 군으로부터 하나 이상 선택된 안정화제를 포함하는 구내염 치료용 액상 조성물.
- 제1항에 있어서, 상기 안정화제가 EDTA 디소듐염, L-히스티딘, L-라이신 염산염, L-아르기닌 염산염, 또는 평균 분자량이 40,000∼100,000 Da인 덱스트란인 것을 특징으로 하는 조성물.
- 제1항에 있어서, 상기 안정화제가 EDTA 디소듐염 또는 L-히스티딘인 것을 특징으로 하는 조성물.
- 제1항에 있어서, 상기 안정화제의 함량이 총 조성물에 대하여 0.01 ∼ 10 w/v%인 것을 특징으로 하는 액상 조성물.
- 제1항에 있어서, 상기 점착성 고분자가 하이드록시프로필 메틸 셀룰로오즈, 카르복시메틸 셀룰로오즈 나트륨, 히아루론산 나트륨, 카보머, 폴리옥시에틸렌과 폴리옥시프로필렌과의 공중합체, 잔탄 검, 젤란 검, 풀루란, 펙틴, 또는 전분류인 것을 특징으로 하는 액상 조성물.
- 제1항에 있어서, 상기 점착성 고분자가 중량평균분자량 7,000 내지 15,000의 폴리옥시에틸렌과 폴리옥시프로필렌과의 공중합체인 것을 특징으로 하는 액상 조성물.
- 제1항에 있어서, 상기 점착성 고분자의 함량이 총 조성물에 대하여 0.01 ∼ 20 w/v%인 것을 특징으로 하는 액상 조성물.
- 제1항에 있어서, 상기 상피세포성장인자의 함량이 총 조성물에 대하여 0.0001 내지 0.01 w/v%인 것을 특징으로 하는 액상 조성물.
- 제1항 내지 제8항 중 어느 한 항에 따른 액상 조성물을 함유하는 구내염 치료용 스프레이.
- 제9항에 있어서, (a) 점착성 고분자를 포함하는 용제부 및 (b) 상피세포성장인자 및 안정화제를 포함하는 주성분부를 별도의 용기에 포함하는 용시 조제용 스프레이.
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060097734A KR100784134B1 (ko) | 2006-10-09 | 2006-10-09 | 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 |
TW096137828A TWI370741B (en) | 2006-10-09 | 2007-10-09 | Stable liquid compositions for treating stomatitis comprising epidermal growth factor |
JP2009532289A JP2010505942A (ja) | 2006-10-09 | 2007-10-09 | 上皮細胞増殖因子を含有する安定な口内炎治療用液状組成物 |
MYPI20091421A MY144321A (en) | 2006-10-09 | 2007-10-09 | Stable liquid compositions for treating stomatitis comprising epidermal growth factor |
CN2007800437524A CN101541305B (zh) | 2006-10-09 | 2007-10-09 | 用以处理口腔炎的包含表皮成长因子的稳定液体组成物 |
EP07833222A EP2083797A4 (en) | 2006-10-09 | 2007-10-09 | STABLE LIQUID COMPOSITIONS FOR TREATING A STOMATITIS COMPRISING AN EPIDERMAL GROWTH FACTOR |
PCT/KR2007/004911 WO2008044852A1 (en) | 2006-10-09 | 2007-10-09 | Stable liquid compositions for treating stomatitis comprising epidermal growth factor |
US12/444,961 US9155697B2 (en) | 2006-10-09 | 2007-10-09 | Stable liquid compositions for treating stomatitis comprising epidermal growth factor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060097734A KR100784134B1 (ko) | 2006-10-09 | 2006-10-09 | 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100784134B1 true KR100784134B1 (ko) | 2007-12-12 |
Family
ID=39140442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060097734A KR100784134B1 (ko) | 2006-10-09 | 2006-10-09 | 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9155697B2 (ko) |
EP (1) | EP2083797A4 (ko) |
JP (1) | JP2010505942A (ko) |
KR (1) | KR100784134B1 (ko) |
CN (1) | CN101541305B (ko) |
MY (1) | MY144321A (ko) |
TW (1) | TWI370741B (ko) |
WO (1) | WO2008044852A1 (ko) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100190735A1 (en) * | 2006-03-28 | 2010-07-29 | Myrex Pharmaceuticals Inc. | Mouthwash and Method of Using Same for the Treatment of Mucositis or Stomatitis |
US8221994B2 (en) | 2009-09-30 | 2012-07-17 | Cilag Gmbh International | Adhesive composition for use in an immunosensor |
AU2012202981B2 (en) * | 2009-09-30 | 2014-01-23 | Cilag Gmbh International | Adhesive Composition for Use in an Immunosensor |
PL3072180T3 (pl) | 2013-11-19 | 2019-09-30 | Aqua Metals Inc. | Urządzenia i sposób recyklingu bez wytapiania akumulatorów kwasowo-ołowiowych |
EP3294931A4 (en) | 2015-05-13 | 2018-12-26 | Aqua Metals Inc. | Electrodeposited lead composition, methods of production, and uses |
DK3294916T3 (da) | 2015-05-13 | 2021-02-15 | Aqua Metals Inc | Systemer og fremgangsmåder til genindvinding af bly fra blysyrebatterier |
HUE055614T2 (hu) | 2015-05-13 | 2021-12-28 | Aqua Metals Inc | Zárt hurok rendszerek, és eljárások ólom-sav akkumulátorok újra feldolgozásához |
US10316420B2 (en) | 2015-12-02 | 2019-06-11 | Aqua Metals Inc. | Systems and methods for continuous alkaline lead acid battery recycling |
WO2019099965A1 (en) * | 2017-11-20 | 2019-05-23 | Just Biotherapeutics, Inc. | Aflibercept formulations containing a lysine salt as tonicifying agent and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010081888A (ko) * | 2000-02-21 | 2001-08-29 | 윤재승 | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 |
Family Cites Families (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ222413A (en) | 1986-11-05 | 1991-06-25 | Ethicon Inc | Compositions containing a polypeptide growth factor and a water-soluble cellulose polymer stabiliser |
US4717717A (en) * | 1986-11-05 | 1988-01-05 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
US5705485A (en) * | 1987-09-18 | 1998-01-06 | Ethicon, Inc. | Gel formulations containing growth factors |
NZ226171A (en) | 1987-09-18 | 1990-06-26 | Ethicon Inc | Gel formulation containing polypeptide growth factor |
US5102870A (en) | 1989-04-14 | 1992-04-07 | Schering Ag | Treatment and prevention of oral mucositis with growth factors |
US5130298A (en) * | 1989-05-16 | 1992-07-14 | Ethicon, Inc. | Stabilized compositions containing epidermal growth factor |
US5272135A (en) * | 1991-03-01 | 1993-12-21 | Chiron Ophthalmics, Inc. | Method for the stabilization of methionine-containing polypeptides |
EP0648113A4 (en) * | 1992-04-23 | 1996-12-04 | Berlex Lab | BIOADHAESIVE FIXED MINERAL OIL EMULSION. |
KR960013439B1 (ko) * | 1993-04-26 | 1996-10-05 | 주식회사 대웅제약 | 안정한 상피세포 성장인자(egf) 조성물 |
SE9400036D0 (sv) * | 1994-01-10 | 1994-01-10 | Pharmacia Ab | Low modecular weight hyaluronic acid |
US5580856A (en) * | 1994-07-15 | 1996-12-03 | Prestrelski; Steven J. | Formulation of a reconstituted protein, and method and kit for the production thereof |
TWI240627B (en) | 1996-04-26 | 2005-10-01 | Chugai Pharmaceutical Co Ltd | Erythropoietin solution preparation |
WO1999009992A1 (fr) * | 1997-08-27 | 1999-03-04 | Yoshitomi Pharmaceutical Industries, Ltd. | Promoteurs de neovascularisation |
WO1999032135A1 (en) * | 1997-12-22 | 1999-07-01 | Human Genome Sciences, Inc. | Keratinocyte growth factor-2 formulations |
JP2000056344A (ja) * | 1998-06-05 | 2000-02-25 | Fuji Xerox Co Ltd | 光導波路素子およびその製造方法 |
AU3327000A (en) | 1999-03-24 | 2000-10-09 | Seikagaku Corporation | Artificial saliva |
US6458387B1 (en) * | 1999-10-18 | 2002-10-01 | Epic Therapeutics, Inc. | Sustained release microspheres |
ATE243049T1 (de) * | 1999-12-09 | 2003-07-15 | Biosyntech Canada Inc | Mineral-polymer hybrid-zusammensetzung |
JP5058404B2 (ja) * | 2000-07-03 | 2012-10-24 | 株式会社シリウス | スロットマシン |
EP1930024A3 (en) | 2000-09-01 | 2008-08-06 | Chugai Seiyaku Kabushiki Kaisha | G-CSF solution formulations having long-term stability |
US7544348B2 (en) * | 2001-02-15 | 2009-06-09 | Access Pharmaceuticals, Inc. | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |
JP2002255852A (ja) | 2001-03-01 | 2002-09-11 | Toa Eiyo Ltd | 口内炎用スプレー製剤 |
CN1129452C (zh) | 2001-04-10 | 2003-12-03 | 王非 | 表皮生长因子口含片 |
US7202066B2 (en) | 2002-01-29 | 2007-04-10 | Carrington Laboratories, Inc. | Combination of a growth factor and a protease enzyme |
AU2003268664A1 (en) * | 2002-09-26 | 2004-04-19 | Shionogi And Co., Ltd. | Stabilized protein compositions |
EP1596822A2 (en) | 2003-02-17 | 2005-11-23 | Sun Pharmaceuticals Industries Ltd. | A low dose corticosteroid composition |
EP1532983A1 (en) * | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Immunoglobulin preparations having increased stability |
KR20050055858A (ko) | 2003-12-09 | 2005-06-14 | 주식회사 엘지생활건강 | 구강 약물 전달 시스템 |
FI20041425A0 (fi) | 2004-11-05 | 2004-11-05 | Orion Corp | Transmukosaalinen veterinäärinen koostumus |
CN101084008B (zh) * | 2004-12-15 | 2013-04-10 | 比奥维特罗姆股份公开公司 | 角质形成细胞生长因子的治疗制剂 |
NZ555386A (en) * | 2004-12-22 | 2011-01-28 | Ambrx Inc | Formulations of human growth hormone comprising a non-naturally encoded amino acid |
CA2600836A1 (en) * | 2005-03-08 | 2006-09-14 | Pharmacia & Upjohn Company Llc | Composition comprising an antibody against macrophage colony-stimulating factor (m-csf) and a chelating agent |
US20080226724A1 (en) * | 2007-01-19 | 2008-09-18 | Genentech, Inc. | Prevention of hydrogel viscosity loss |
-
2006
- 2006-10-09 KR KR1020060097734A patent/KR100784134B1/ko active IP Right Grant
-
2007
- 2007-10-09 CN CN2007800437524A patent/CN101541305B/zh active Active
- 2007-10-09 WO PCT/KR2007/004911 patent/WO2008044852A1/en active Application Filing
- 2007-10-09 TW TW096137828A patent/TWI370741B/zh active
- 2007-10-09 MY MYPI20091421A patent/MY144321A/en unknown
- 2007-10-09 JP JP2009532289A patent/JP2010505942A/ja active Pending
- 2007-10-09 US US12/444,961 patent/US9155697B2/en active Active
- 2007-10-09 EP EP07833222A patent/EP2083797A4/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010081888A (ko) * | 2000-02-21 | 2001-08-29 | 윤재승 | 상피세포 성장인자를 유효성분으로 하는 안정한 약제학적조성물 |
Also Published As
Publication number | Publication date |
---|---|
EP2083797A4 (en) | 2012-10-31 |
US20100035809A1 (en) | 2010-02-11 |
MY144321A (en) | 2011-08-29 |
CN101541305B (zh) | 2012-04-11 |
TW200824719A (en) | 2008-06-16 |
JP2010505942A (ja) | 2010-02-25 |
EP2083797A1 (en) | 2009-08-05 |
US9155697B2 (en) | 2015-10-13 |
WO2008044852A1 (en) | 2008-04-17 |
CN101541305A (zh) | 2009-09-23 |
TWI370741B (en) | 2012-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100784134B1 (ko) | 상피세포성장인자를 함유하는 안정한 구내염 치료용 액상조성물 | |
RU2413501C2 (ru) | Способ получения водного раствора, содержащего бета-циклодекстрин | |
US5102870A (en) | Treatment and prevention of oral mucositis with growth factors | |
KR100748390B1 (ko) | 상피세포성장인자를 포함하는 상처치료용 서방성 필름 제형 | |
EP2252290B1 (en) | Pharmaceutical composition for use in the treatment and/or the prevention of osteoarticular diseases | |
KR20090031726A (ko) | 국소용 조성물 | |
US5801199A (en) | Pharmaceutical composition for treating acute rhinitis | |
JP4152118B2 (ja) | 1,2,3,9−テトラヒドロ−9−メチル−3−[(2−メチル−1h−イミダゾール−1−イル)メチル]−4h−カーバゾール−4−オンを有效成分とする鼻腔噴霧用組成物 | |
CN1814279A (zh) | 重组人碱性成纤维细胞生长因子凝胶剂及其制备方法 | |
US8906883B2 (en) | Treatment of oral mucositis by administering an ionic complex of chitosan and a negatively charged polysaccharide selected from heparin, heparan sulfate and dextran sulfate | |
GB2264235A (en) | Intranasal compositions | |
KR20190109310A (ko) | 레반을 함유하는 염증성 질환 치료용 경비투여형 스프레이 제제 | |
ES2860098T3 (es) | Composición para la aplicación nasal | |
AU2003278962B2 (en) | Nasal compositions comprising a mucopolysaccharide and propylene glycol | |
JP6595717B2 (ja) | 骨関節炎治療のための親水化されたスルファサラジンおよびヒアルロン酸を含む組成物およびその製造方法 | |
JP6629877B2 (ja) | 鼻粘膜投与用医薬組成物 | |
US20160082026A1 (en) | Ganglioside Transmucosal Formulations | |
CN1285382C (zh) | 含海藻糖和玻璃酸的鼻腔用药传递系统及其制备方法 | |
JPH03246233A (ja) | 経粘膜投与用薬剤組成物 | |
JP5930332B2 (ja) | アンブロキソールを含む噴霧可能な組成物の使用 | |
KR20090081083A (ko) | 알긴산류 화합물을 포함하는 점안용 조성물 및 그의제조방법 | |
JP7273257B1 (ja) | 医薬組成物 | |
WO2023100836A1 (ja) | 医薬組成物 | |
US20230331792A1 (en) | New multi-functional oligopeptides | |
TW202400219A (zh) | 用於鼻內給藥的索馬魯肽及其鹽的藥物組合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
G170 | Publication of correction | ||
FPAY | Annual fee payment |
Payment date: 20130327 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20140306 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20150306 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20160329 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20170410 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20180404 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20190402 Year of fee payment: 13 |